Deregulated transcription factors in cancer cell metabolisms and reprogramming

R Kant, RK Manne, M Anas, V Penugurti, T Chen… - Seminars in cancer …, 2022 - Elsevier
Metabolic reprogramming is an important cancer hallmark that plays a key role in cancer
malignancies and therapy resistance. Cancer cells reprogram the metabolic pathways to …

Deregulated transcription factors in the emerging cancer hallmarks

A Hasan, NA Khan, S Uddin, AQ Khan… - Seminars in Cancer …, 2024 - Elsevier
Cancer progression is a multifaceted process that entails several stages and demands the
persistent expression or activation of transcription factors (TFs) to facilitate growth and …

PM2. 5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming

Q Chen, Y Wang, L Yang, L Sun, Y Wen… - Journal of Experimental …, 2022 - Springer
Background Airborne fine particulate matter (PM2. 5) has been associated with lung cancer
development and progression in never smokers. However, the molecular mechanisms …

Moonlighting proteins: the case of the hexokinases

C Rodríguez-Saavedra… - Frontiers in Molecular …, 2021 - frontiersin.org
Moonlighting proteins are defined as proteins with two or more functions that are unrelated
and independent to each other, so that inactivation of one of them should not affect the …

Transcription and translation inhibitors in cancer treatment

N Laham-Karam, GP Pinto, A Poso… - Frontiers in …, 2020 - frontiersin.org
Transcription and translation are fundamental cellular processes that govern the protein
production of cells. These processes are generally up regulated in cancer cells, to maintain …

m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer

JX Lin, NZ Lian, YX Gao, QL Zheng, YH Yang… - Cell death & …, 2022 - nature.com
LHPP, a histidine phosphatase, has been implicated in tumour progression. However, its
role, underlying mechanisms, and prognostic significance in human gastric cancer (GC) are …

Chrysophanol inhibits of colorectal cancer cell motility and energy metabolism by targeting the KITENIN/ErbB4 oncogenic complex

M Varlı, E Kim, S Oh, S Pulat, R Zhou… - Cancer Cell …, 2024 - Springer
Background Expression of the KITENIN/ErbB4 oncogenic complex is associated with
metastasis of colorectal cancer to distant organs and lymph nodes and is linked with poor …

[HTML][HTML] Bio-Pathological Functions of Posttranslational Modifications of Histological Biomarkers in Breast Cancer

AN Neagu, CL Josan, TM Jayaweera, H Morrissiey… - Molecules, 2024 - mdpi.com
Proteins are the most common types of biomarkers used in breast cancer (BC) theranostics
and management. By definition, a biomarker must be a relevant, objective, stable, and …

Identification of characteristic metabolic panels for different stages of prostate cancer by 1H NMR-based metabolomics analysis

X Zhang, B **a, H Zheng, J Ning, Y Zhu, X Shao… - Journal of Translational …, 2022 - Springer
Abstract Background Prostate cancer (PCa) is the second most prevalent cancer in males
worldwide, yet detecting PCa and its metastases remains a major challenging task in clinical …

PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2

W Du, N Liu, Y Zhang, X Liu, Y Yang… - Biochemistry and cell …, 2020 - cdnsciencepub.com
The purpose of this study was to characterize the expression of procollagen-lysine, 2-
oxoglutarate 5-dioxygenase 2 (PLOD2), a membrane-bound homodimeric enzyme that …